WESTLAKE VILLAGE, Calif., Dec. 03, 2003 (PRIMEZONE) -- QT 5, Inc. (OTCBB:QTFV), manufacturer and marketers of NICOWater(tm), the breakthrough Homeopathic Nicotinum (nicotine) product designed to relieve the symptoms of tobacco cravings, today announced an exclusive distribution agreement with Mission Beverage Co. of Los Angeles, California. Mission will provide the availability of NICOWater(tm) to over 10,000 retail locations within the Los Angeles metropolitan market. These retail accounts include over 5,000 on-premise dealers such as bars, restaurants and hotels as well as almost 6,000 convenience locations including mini-marts, liquor stores and a number of outlets within LAX airport terminals.
"In 1998 California was among the first states to become smoke-free," notes Steven H. Reder, QT 5, Inc. President. "With almost 2 Million smokers in Los Angeles County alone, the geographic area served by Mission Beverage Co. is paramount to NICOWater(tm)'s rate of success. We have done our homework and diligently executed all plans and preparations for introducing NICOWater(tm) to the world. In our quest for strategic distribution partners, Mission Beverage Co. was identified as an optimum candidate to anchor our Southern California efforts. There are only a handful of companies that even approach the strength of their retail network. After identifying and carefully researching all of them, we are confident that our new partnership with Mission will provide the maximum short and long term mutual benefit."
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing and Homeopathic products. QT 5, Inc. currently manufactures and markets NICOWater, its breakthrough Homeopathic Nicotinum (nicotine) product designed to relieve the symptoms of tobacco cravings. QT 5 continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: www.qt5inc.com. NICOWater(tm) is a Homeopathic Drug product that is sold under the FDA's Compliance Policy Guide Conditions Under Which Homeopathic Drugs May Be Marketed.
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.